CA2986273A1 - Soluble and stable heterodimeric tcr - Google Patents

Soluble and stable heterodimeric tcr

Info

Publication number
CA2986273A1
CA2986273A1 CA2986273A CA2986273A CA2986273A1 CA 2986273 A1 CA2986273 A1 CA 2986273A1 CA 2986273 A CA2986273 A CA 2986273A CA 2986273 A CA2986273 A CA 2986273A CA 2986273 A1 CA2986273 A1 CA 2986273A1
Authority
CA
Canada
Prior art keywords
tcr
chain
exon
interchain disulfide
trbc2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2986273A
Other languages
English (en)
French (fr)
Inventor
Yi Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xlifesc Ltd
Original Assignee
Guangdong Xiangxue Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Xiangxue Life Sciences Ltd filed Critical Guangdong Xiangxue Life Sciences Ltd
Publication of CA2986273A1 publication Critical patent/CA2986273A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
CA2986273A 2015-05-20 2016-03-29 Soluble and stable heterodimeric tcr Abandoned CA2986273A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510260322.4A CN106279404A (zh) 2015-05-20 2015-05-20 一种可溶且稳定的异质二聚tcr
CN201510260322.4 2015-05-20
PCT/CN2016/077680 WO2016184258A1 (zh) 2015-05-20 2016-03-29 一种可溶且稳定的异质二聚tcr

Publications (1)

Publication Number Publication Date
CA2986273A1 true CA2986273A1 (en) 2016-11-24

Family

ID=57319412

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2986273A Abandoned CA2986273A1 (en) 2015-05-20 2016-03-29 Soluble and stable heterodimeric tcr

Country Status (6)

Country Link
US (1) US10316087B2 (cg-RX-API-DMAC7.html)
EP (1) EP3299389A4 (cg-RX-API-DMAC7.html)
JP (1) JP6640994B2 (cg-RX-API-DMAC7.html)
CN (2) CN106279404A (cg-RX-API-DMAC7.html)
CA (1) CA2986273A1 (cg-RX-API-DMAC7.html)
WO (1) WO2016184258A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117843810A (zh) 2017-09-22 2024-04-09 上海药明生物技术有限公司 新型双特异性多肽复合物
CN110016074B (zh) * 2018-01-08 2021-03-30 中国科学院广州生物医药与健康研究院 Mage-a3人源化t细胞受体
EP3917969A4 (en) * 2019-01-28 2023-02-01 Wuxi Biologics Ireland Limited NEW BISPECIFIC CD3/CD20 POLYPEPTIDIC COMPLEXES
CN112442119B (zh) * 2019-09-05 2023-02-24 香雪生命科学技术(广东)有限公司 一种识别ssx2的高亲和力t细胞受体
CN113880953A (zh) 2020-07-01 2022-01-04 华夏英泰(北京)生物技术有限公司 T细胞抗原受体、其多聚体复合物及其制备方法和应用
IL318522A (en) * 2022-07-28 2025-03-01 Hadasit Med Res Service Engineered T-cell receptor constructs for cancer treatment
CN120418298A (zh) 2022-12-19 2025-08-01 北京永泰生物制品有限公司 T细胞抗原受体及其制备方法和应用
CN118108833B (zh) * 2024-03-12 2025-05-02 缇纱(合肥)生物技术有限公司 引入外源二硫键的tcr恒定区及其产品和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ507886A (en) * 1998-05-19 2003-05-30 Avidex Ltd Multivalent T cell receptor complexes
WO2000006733A2 (en) * 1998-07-29 2000-02-10 Heska Corporation T cell receptor proteins, nucleic acid molecules, and uses thereof
PT1421115E (pt) * 2001-08-31 2005-07-29 Avidex Ltd Receptor de celulas t soluvel
US6913941B2 (en) * 2002-09-09 2005-07-05 Freescale Semiconductor, Inc. SOI polysilicon trench refill perimeter oxide anchor scheme
GB0227351D0 (en) * 2002-11-22 2002-12-31 Isis Innovation Soluble T-cell receptors
JP2006523437A (ja) * 2002-12-03 2006-10-19 アヴィデックス リミテッド レセプター複合体
GB0304068D0 (en) * 2003-02-22 2003-03-26 Avidex Ltd Substances
WO2005113595A2 (en) * 2004-05-19 2005-12-01 Avidex Ltd High affinity ny-eso t cell receptor
EP1809669A2 (en) * 2004-10-01 2007-07-25 Avidex Ltd T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents
JP2013535199A (ja) * 2010-07-28 2013-09-12 イムノコア リミテッド T細胞レセプター
EP2502934B1 (en) * 2011-03-24 2018-01-17 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
JP6549564B2 (ja) * 2013-06-26 2019-07-24 グアンドン シャンスエ ライフ サイエンス, リミテッド. 高安定性のt細胞受容体およびその製法と使用
GB201313377D0 (en) * 2013-07-26 2013-09-11 Adaptimmune Ltd T cell receptors
GB201314404D0 (en) * 2013-08-12 2013-09-25 Immunocore Ltd T Cell Receptors

Also Published As

Publication number Publication date
JP2018522061A (ja) 2018-08-09
US20180201682A1 (en) 2018-07-19
CN106279404A (zh) 2017-01-04
US10316087B2 (en) 2019-06-11
EP3299389A4 (en) 2018-11-21
WO2016184258A1 (zh) 2016-11-24
JP6640994B2 (ja) 2020-02-05
CN107108717A (zh) 2017-08-29
CN107108717B (zh) 2021-04-23
EP3299389A1 (en) 2018-03-28

Similar Documents

Publication Publication Date Title
AU2017204047B2 (en) High-stability T-cell receptor and preparation method and application thereof
US10316087B2 (en) Soluble and stable heterodimeric TCR
WO2019109821A1 (zh) 针对prame的高亲和力t细胞受体
CN112759641B (zh) 一种识别Kras G12V的高亲和力TCR
CN106459177B (zh) 高亲和力ny-eso t细胞受体
CN111662374B (zh) 一种识别afp抗原的高亲和力tcr
US11851469B2 (en) Soluble heterodimeric T cell receptor, and preparation method and use thereof
JP2022095667A (ja) Ny-esoに対する高親和力のtcr
CN106432475B (zh) 高亲和力ny-eso t细胞受体
CN112442119B (zh) 一种识别ssx2的高亲和力t细胞受体
JP2026514918A (ja) Kras突然変異を識別する高親和性t細胞受容体及びその応用
WO2023221959A1 (zh) 一种识别mage的高亲和力t细胞受体及其应用
CN117659163A (zh) 一种识别afp的高亲和力t细胞受体及其应用
CN112300268B (zh) 识别ny-eso-1抗原的高亲和力t细胞受体
CN116836261A (zh) 一种识别mage-a4抗原的高亲和力tcr及其序列和应用
WO2022206860A1 (zh) 针对afp的t细胞受体
WO2022262842A1 (zh) 一种针对afp抗原的高亲和力t细胞受体
WO2023005859A1 (zh) 针对抗原ssx2的高亲和力t细胞受体
CN115819555A (zh) 一种识别ssx2的高亲和力tcr

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210329

FZDE Discontinued

Effective date: 20240228